Alpha-1-antitrypsin deficiency: Current concepts

Lung

Volumn 185, Issue 4, 2007, Pages 191-201

  Mulgrew, Alan T ^a   Taggart, Clifford C ^b   McElvaney, N Gerry ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BEAUMONT HOSPITAL   (Ireland)

Author keywords

Alpha 1 antitrypsin; Emphysema; Interleukin 8; Liver disease; Neutrophil chemotaxis; Polymers; Protease; Review

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BETA LACTAM; BRONCHODILATING AGENT; DEXAMETHASONE; HEPATITIS B VACCINE; INFLUENZA VACCINE; INTERLEUKIN 1; INTERLEUKIN 8; KETONE DERIVATIVE; ONCOSTATIN M; PARVOVIRUS VECTOR; PNEUMOCOCCUS VACCINE; POLYMER; PROTEINASE; STEROID;

ALPHA 1 ANTITRYPSIN DEFICIENCY; CELL BASED GENE THERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CONFORMATIONAL TRANSITION; DISEASE COURSE; ENDOPLASMIC RETICULUM; GENE MUTATION; GENETIC VARIABILITY; HEPATITIS; HUMAN; INFLUENZA; LIVER CELL; LIVER CIRRHOSIS; LIVER DISEASE; LUNG DISEASE; LUNG EMPHYSEMA; LUNG FUNCTION; LUNG HEMORRHAGE; LUNG TRANSPLANTATION; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN FUNCTION; REVIEW; SCREENING TEST; SEX CHROMOSOME; STREPTOCOCCUS PNEUMONIA; STRUCTURE ACTIVITY RELATION; VIRAL GENE THERAPY;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; HUMANS; LIVER DISEASES; LUNG DISEASES;

EID: 34547097491     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00408-007-9009-y     Document Type: Review

References (119)

1. Potempa J, Korzus E, Travis J (1994) The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J Biol Chem 269(23):15957-15960
2. Carrell RW (1986) Serpins: the superfamily of serine proteinase inhibitors. In: Barrett A (eds) Proteinase Inhibitors. Amsterdam: Elsevier Biomedical Press, pp 403-419
3. Rogers J, Kalsheker N, Wallis S, Speer A, Coutelle CH, Woods D, Humphries SE (1983) The isolation of a clone for human alpha 1-antitrypsin and the detection of alpha 1-antitrypsin in mRNA from liver and leukocytes. Biochem Biophys Res Commun 116(2):375-382
4. Carlson JA, Rogers BB, Sifers RN, Hawkins HK, Finegold MJ, Woo SL (1988) Multiple tissues express alpha 1-antitrypsin in transgenic mice and man. J Clin Invest 82(1):26-36
5. Molmenti EP, Perlmutter DH, Rubin DC (1993) Cell-specific expression of alpha 1-antitrypsin in human intestinal epithelium. J Clin Invest 92(4):2022-2034
6. Muir AL, Cruz M, Martin BA, Thommasen H, Belzberg A, Hogg JC (1984) Leukocyte kinetics in the human lung: role of exercise and catecholamines. J Appl Physiol 57(3):711-719
7. Janoff A (1985) Elastase in tissue injury. Annu Rev Med 36:207-216
8. Chino K, Choong CK, Toeniskoetter PD, Cooper JD, Lausberg HF, Bae KT, Pierce JA, Hogg JC (2004) A canine model for production of severe unilateral panacinar emphysema. Exp Lung Res 30(4):319-332
9. Sloan B, Abrams WR, Meranze DR, Kimbel P, Weinbaum G (1981) Emphysema induced in vitro and in vivo in dogs by a purified elastase from homologous leukocytes. Am Rev Respir Dis 124(3):295-301
10. Knoell DL, Ralston DR, Coulter KR, Wewers MD (1998) Alpha 1-antitrypsin and protease complexation is induced by lipopolysaccharide, interleukin-1beta, and tumor necrosis factor-alpha in monocytes. Am J Respir Crit Care Med 157(1):246-255
11. Hutchison DC (1990) Epidemiology of alpha 1-protease inhibitor deficiency. Eur Respir J Suppl 9:29s-34s
12. de Serres FJ (2002) Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest 122(5):1818-1829
13. Curiel DT, Chytil A, Courtney M, Crystal RG (1989) Serum alpha 1-antitrypsin deficiency associated with the common S-type (Glu264-Val) mutation results from intracellular degradation of alpha 1-antitrypsin prior to secretion. J Biol Chem 264(18):10477-10486
14. Elliott PR, Stein PE, Bilton D, Carrell RW, Lomas DA (1996) Structural explanation for the deficiency of S alpha 1-antitrypsin. Nat Struct Biol 3(11):910-911
15. Lomas DA, Evans DL, Finch JT, Carrell RW (1992) The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 357(6379):605-607
16. Elliott PR, Bilton D, Lomas DA (1998) Lung polymers in Z alpha1-antitrypsin deficiency-related emphysema. Am J Respir Cell Mol Biol 18(5):670-674
17. Janciauskiene S, Dominaitiene R, Stemby NH, Piitulainen E, Eriksson S (2002) Detection of circulating and endothelial cell polymers of Z and wild type alpha 1-antitrypsin by a monoclonal antibody. J Biol Chem 277(29):26540-26546
18. Evald T, Dirksen A, Keittelmann S, Viskum K, Kok-Jensen A (1990) Decline in pulmonary function in patients with alpha 1-antitrypsin deficiency. Lung 168 Suppl:579-585
19. Larsson C (1978) Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z. Acta Med Scand 204(5):345-351
20. Kueppers F, Black LF (1974) Alpha1-antitrypsin and its deficiency. Am Rev Respir Dis 110(2):176-194
21. Brantly ML, Paul LD, Miller BH, Falk RT, Wu M, Crystal RG (1988) Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis 138(2):327-336
22. Colp C, Pappas J, Moran D, Lieberman J (1993) Variants of alpha 1-antitrypsin in Puerto Rican children with asthma. Chest 103(3):812-815
23. Cook L, Janus ED, Brenton S, Tai E, Burdon J (1994) Absence of alpha-1-antitrypsin (Pi Null Bellingham) and the early onset of emphysema. Aust N Z J Med 24(3):263-269
24. Silverman EK, Miletich JP, Pierce JA, Sherman LA, Endicott SK, Broze GJ Jr, Campbell EJ (1989) Alpha-1-antitrypsin deficiency. High prevalence in the St. Louis area determined by direct population screening. Am Rev Respir Dis 140(4):961-966
25. Christen H, Henke J (1976) [Clinical, clinical-chemical and pathological findings in familial alpha1-antitrypsin deficiency]. Monatsschr Kinderheilkd 124(5):384-386
26. Gishen P, Saunders AJ, Tobin MJ, Hutchison DC (1982) Alpha 1-antitrypsin deficiency: the radiological features of pulmonary emphysema in subjects of Pi type Z and Pi type SZ: a survey by the British Thoracic Association. Clin Radiol 33(4):371-377
27. Tobin MJ, Cook PJ, Hutchison DC (1983) Alpha 1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British Thoracic Association. Br J Dis Chest 77(1):14-27
28. Wall M, Moe E, Eisenberg J, Powers M, Buist N, Buist AS (1990) Long-term follow-up of a cohort of children with alpha-1-antitrypsin deficiency. J Pediatr 116(2):248-251
29. Buist AS, Burrows B, Eriksson S, Mittman C, Wu M (1983) The natural history of air-flow obstruction in PiZ emphysema. Report of an NHLBI workshop. Am Rev Respir Dis 127(2):S43-S45
30. Janus ED, Phillips NT, Carrell RW (1985) Smoking, lung function, and alpha 1-antitrypsin deficiency. Lancet 1(8421):152-154
31. Wu MC, Eriksson S (1988) Lung function, smoking and survival in severe alpha 1-antitrypsin deficiency, PiZZ. J Clin Epidemiol 41(12):1157-1165
32. Fallat RJ, Powell MR, Kueppers F, Lilker E (1973) 133 Xe ventilatory studies in 1-antitrypsin deficiency. J Nucl Med 14(1):5-13
33. Guest PJ, Hansell DM (1992) High resolution computed tomography (HRCT) in emphysema associated with alpha-1-antitrypsin deficiency. Clin Radiol 45(4):260-266
34. Shin MS, Ho KJ (1993) Bronchiectasis in patients with alpha 1-antitrypsin deficiency. A rare occurrence? Chest 104(5):1384-1386
35. King MA, Stone JA, Diaz PT, Mueller CF, Becker WJ, Gadek JE (1996) Alpha 1-antitrypsin deficiency: evaluation of bronchiectasis with CT. Radiology 199(1):137-141
36. Dirksen A, Friis M, Olesen KP, Skovgaard LT, Sorensen K (1997) Progress of emphysema in severe alpha 1-antitrypsin deficiency as assessed by annual CT. Acta Radiol 38(5):826-832
37. Shaker SB, Dirksen A, Laursen LC, Maltbaek N, Christensen L, Sander U, Seersholm N, Skovgaard LT, Nielsen L, Kok-Jensen A (2004) Short-term reproducibility of computed tomography-based lung density measurements in alpha-1 antitrypsin deficiency and smokers with emphysema. Acta Radiol 45(4):424-430
38. Eriksson S, Carlson J, Velez R (1986) Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. N Engl J Med 314(12):736-739
39. Sveger T (1988) The natural history of liver disease in alpha 1-antitrypsin deficient children. Acta Paediatr Scand 77(6):847-851
40. Birrer P, McElvaney NG, Chang-Stroman LM, Crystal RG (1991) Alpha 1-antitrypsin deficiency and liver disease. J Inherit Metab Dis 14(4):512-525
41. Psacharopoulos HT, Mowat AP, Cook PJ, Carlile PA, Portmann B, Rodeck CH (1983) Outcome of liver disease associated with alpha 1 antitrypsin deficiency (PiZ). Implications for genetic counselling and antenatal diagnosis. Arch Dis Child 58(11):882-887
42. Cox DW, Smyth S (1983) Risk for liver disease in adults with alpha 1-antitrypsin deficiency. Am J Med 74(2):221-227
43. Feldmann G, Bignon J, Chahinian P, Degott C, Benhamou JP (1974) Hepatocyte ultrastructural changes in alpha1-antitrypsin deficiency. Gastroenterology 67(6):1214-1224
44. Govindarajan S, Ashcavai M, Peters RL (1981) Alpha-1-Antitrypsin phenotypes in hepatocellular carcinoma. Hepatology 1(6):628-631
45. Perlmutter DH (2006) Pathogenesis of chronic liver injury and hepatocellular carcinoma in alpha-1-antitrypsin deficiency. Pediatr Res 60(2):233-238
46. Sveger T (1976) Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 294(24):1316-1321
47. Sveger T, Eriksson S (1995) The liver in adolescents with alpha 1-antitrypsin deficiency. Hepatology 22(2):514-517
48. Wu Y, Whitman I, Molmenti E, Moore K, Hippenmeyer P, Perlmutter DH (1994) A lag in intracellular degradation of mutant alpha 1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency. Proc Natl Acad Sci U S A 91(19):9014-9018
49. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, White GA, O'Riordan CR, Smith AE (1990) Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63(4):827-834
50. Inoue S, Simoni RD (1992) 3-Hydroxy-3-methylglutaryl-coenzyme A reductase and T cell receptor alpha subunit are differentially degraded in the endoplasmic reticulum. J Biol Chem 267(13):9080-9086
51. Qu D, Teckman JH, Omura S, Perlmutter DH (1996) Degradation of a mutant secretory protein, alpha1-antitrypsin Z, in the endoplasmic reticulum requires proteasome activity. J Biol Chem 271(37):22791-22795
52. Teckman JH, Burrows J, Hidvegi T, Schmidt B, Hale PD, Perlmutter DH (2001) The proteasome participates in degradation of mutant alpha 1-antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes. J Biol Chem 276(48):44865-44872
53. Novoradovskaya N, Lee J, Yu ZX, Ferrans VJ, Brantly M (1998) Inhibition of intracellular degradation increases secretion of a mutant form of alpha1-antitrypsin associated with profound deficiency. J Clin Invest 101(12):2693-2701
54. Cabral CM, Choudhury P, Liu Y, Sifers RN (2000) Processing by endoplasmic reticulum mannosidases partitions a secretion-impaired glycoprotein into distinct disposal pathways. J Biol Chem 275(32):25015-25022
55. Travers KJ, Patil CK, Wodicka L, Lockhart DJ, Weissman JS, Walter P (2000) Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell 101(3):249-258
56. Friedlander R, Jarosch E, Urban J, Volkwein C, Sommer T (2000) A regulatory link between ER-associated protein degradation and the unfolded-protein response. Nat Cell Biol 2(7):379-384
57. Pittelkow MR, Smith KC, Su WP (1988) Alpha-1-antitrypsin deficiency and panniculitis. Perspectives on disease relationship and replacement therapy. Am J Med 84(6A):80-86
58. Strife CF, Hug G, Chuck G, McAdams AJ, Davis CA, Kline JJ (1983) Membranoproliferative glomerulonephritis and alpha 1-antitrypsin deficiency in children. Pediatrics 71(1):88-92
59. Ibarguen E, Gross CR, Savik SK, Sharp HL (1990) Liver disease in alpha-1-antitrypsin deficiency: prognostic indicators. J Pediatr 117(6):864-870
60. Cox DW (1994) Alpha 1-antitrypsin: a guardian of vascular tissue. Mayo Clin Proc 69(11):1123-1124
61. Elzouki AN, Segelmark M, Wieslander J, Eriksson S (1994) Strong link between the alpha 1-antitrypsin PiZ allele and Wegener's granulomatosis. J Intern Med 236(5):543-548
62. Rooney CP, Taggart C, Coakley R, McElvaney NG, O'Neill SJ (2001) Anti-proteinase 3 antibody activation of neutrophils can be inhibited by alpha1-antitrypsin. Am J Respir Cell Mol Biol 24(6):747-754
63. Eriksson S, Moestrup T, Hagerstrand I (1975) Liver, lung and malignant disease in heterozygous (Pi MZ) alpha1-antitrypsin deficiency. Acta Med Scand 198(4):243-247
64. Carrell RW, Lomas DA (2002) Alpha1-antitrypsin deficiency-a model for conformational diseases. N Engl J Med 346(1):45-53
65. Crowther DC (2002) Familial conformational diseases and dementias. Hum Mutat 20(1):1-14
66. Cichy J, Potempa J, Travis J (1997) Biosynthesis of alpha1-proteinase inhibitor by human lung-derived epithelial cells. J Biol Chem 272(13):8250-8255
67. Boutten A, Venembre P, Seta N, Hamelin J, Aubier M, Durand G, Dehoux MS (1998) Oncostatin M is a potent stimulator of alpha1-antitrypsin secretion in lung epithelial cells: modulation by transforming growth factor-beta and interferon-gamma. Am J Respir Cell Mol Biol 18(4):511-520
68. Kalsheker N, Morley S, Morgan K (2002) Gene regulation of the serine proteinase inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin. Biochem Soc Trans 30(2):93-98
69. Mulgrew AT, Taggart CC, Lawless MW, Greene CM, Brantly ML, O'Neill SJ, McElvaney NG (2004) Z alpha1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant. Chest 125(5):1952-1957
70. Gadek JE, Pacht ER (1990) The protease-antiprotease balance within the human lung: implications for the pathogenesis of emphysema. Lung 168 Suppl:552-564
71. Parmar JS, Mahadeva R, Reed BJ, Farahi N, Cadwallader KA, Keogan MT, Bilton D, Chilvers ER, Lomas DA (2002) Polymers of alpha(1)-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema. Am J Respir Cell Mol Biol 26(6):723-730
72. Wardell MR, Lomas DA, Brecht WJ, Mahley RW (1994) Protease-complexed and polymerised antithrombin and alpha1-antitrypsin bind low density lipoprotein receptor-related protein. Protein Sci 3(Suppl):S101
73. Banda MJ, Rice AG, Griffin GL, Senior RM (1988) The inhibitory complex of human alpha 1-proteinase inhibitor and human leukocyte elastase is a neutrophil chemoattractant. J Exp Med 167(5):1608-1615
74. Kurdowska A, Travis J (1990) Acute phase protein stimulation by alpha 1-antichymotrypsin-cathepsin G complexes. Evidence for the involvement of interleukin-6. J Biol Chem 265(34):21023-21026
75. Mahadeva R, Atkinson C, Li Z, Stewart S, Janciauskiene S, Kelley DG, Parmar J, Pitman R, Shapiro SD, Lomas DA (2005) Polymers of Z alpha1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo. Am J Pathol 166(2):377-386
76. Lawless MW, Greene CM, Mulgrew A, Taggart CC, O'Neill SJ, McElvaney NG (2004) Activation of endoplasmic reticulum-specific stress responses associated with the conformational disease Z alpha 1-antitrypsin deficiency. J Immunol 172(9):5722-5726
77. Pahl HL, Baeuerle PA (1995) A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NF-kappa B. EMBO J 14(11):2580-2588
78. Sveger T, Thelin T (2000) A future for neonatal alpha1-antitrypsin screening? Acta Paediatr 89(6):628-631
79. Sveger T, Thelin T, McNeil TF (1997) Young adults with alpha 1-antitrypsin deficiency identified neonatally: their health, knowledge about and adaptation to the high-risk condition. Acta Paediatr 86(1):37-40
80. Fleming LE, Oquendo S, Bean JA, Tamer R, Finn S, Wanner A (2001) Pilot detection study of alpha(1) antitrypsin deficiency in a targeted population. Am J Med Genet 103(1):69-74
81. Wencker M, Marx A, Konietzko N, Schaefer B, Campbell EJ (2002) Screening for alpha1-Pi deficiency in patients with lung diseases. Eur Respir J 20(2):319-324
82. Gadek JE, Klein HG, Holland PV, Crystal RG (1981) Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects. J Clin Invest 68(5):1158-1165
83. Wewers MD, Casalaro MA, Sellers SE, Swayze SC, McPhaul KM, Wittes JT, Crystal RG (1987) Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema. N Engl J Med 316(17):1055-1062
84. Seersholm N, Wencker M, Banik N, Viskum K, Dirksen A, Kok-Jensen A, Konietzko N (1997) Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group. Eur Respir J 10(10):2260-2263
85. Gildea TR, Shermock KM, Singer ME, Stoller JK (2003) Cost-effectiveness analysis of augmentation therapy for severe alpha1-antitrypsin deficiency. Am J Respir Crit Care Med 167(10):1387-1392
86. Sandhaus RA (2004) Alpha1-antitrypsin deficiency. 6: new and emerging treatments for alpha1-antitrypsin deficiency. Thorax 59(10):904-909
87. Hubbard RC, Brantly ML, Sellers SE, Mitchell ME, Crystal RG (1989) Anti-neutrophil-elastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin. Ann Intern Med 111(3):206-212
88. Hubbard RC, McElvaney NG, Sellers SE, Healy JT, Czerski DB, Crystal RG (1989) Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency. J Clin Invest 84(4):1349-1354
89. Smith RM, Traber LD, Traber DL, Spragg RG (1989) Pulmonary deposition and clearance of aerosolized alpha-1-proteinase inhibitor administered to dogs and to sheep. J Clin Invest 84(4):1145-1154
90. Kennedy AJ, Cline A, Ney UM, Johnson WH, Roberts NA (1987) The effect of a peptide aldehyde reversible inhibitor of elastase on a human leucocyte elastase-induced model of emphysema in the hamster. Eur J Respir Dis 71(5):472-478
91. Bonney RJ, Ashe B, Maycock A, Dellea P, Hand K, Osinga D, Fletcher D, Mumford R, Davies P, Frankenfield D, et al. (1989) Pharmacological profile of the substituted beta-lactam L-659,286: a member of a new class of human PMN elastase inhibitors. J Cell Biochem 39(1):47-53
92. Skiles JW, Fuchs V, Miao C, Sorcek R, Grozinger KG, Mauldin SC, Vitous J, Mui PW, Jacober S, Chow G, et al. (1992) Inhibition of human leukocyte elastase (HLE) by N-substituted peptidyl trifluoromethyl ketones. J Med Chem 35(4):641-662
93. Hood JM, Koep LJ, Peters RL, Schroter GP, Weil R 3rd, Redeker AG, Starzl TE (1980) Liver transplantation for advanced liver disease with alpha-1-antitrypsin deficiency. N Engl J Med 302(5):272-275
94. Gartner JC Jr, Zitelli BJ, Malatack JJ, Shaw BW, Iwatsuki S, Starzl TE (1984) Orthotopic liver transplantation in children: two-year experience with 47 patients. Pediatrics 74(1):140-145
95. Starzl TE, Porter KA, Francavilla A, Iwatsuki S (1983) Reversal of hepatic alpha-1-antitrypsin deposition after portacaval shunt. Lancet 2(8347):424-426
96. Starzl TE, Porter KA, Busuttil RW, Pichlmayr R (1990) Portacaval shunt in three children with alpha-1-antitrypsin deficiency and cirrhosis: 9 to 12 1/3 years later. Hepatology 11(1):152-154
97. Hussain M, Mieli-Vergani G, Mowat AP (1991) Alpha 1-antitrypsin deficiency and liver disease: clinical presentation, diagnosis and treatment. J Inherit Metab Dis 14(4):497-511
98. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M (1992) Cell migration, chimerism, and graft acceptance. Lancet 339(8809):1579-1582
99. Garver RI Jr, Chytil A, Courtney M, Crystal RG (1987) Clonal gene therapy: transplanted mouse fibroblast clones express human alpha 1-antitrypsin gene in vivo. Science 237(4816):762-764
100. Kolodka TM, Finegold M, Kay MA, Woo SL (1993) Hepatic gene therapy: efficient retroviral-mediated gene transfer into rat hepatocytes in vivo. Somat Cell Mol Genet 19(5):491-497
101. Rosenfeld MA, Siegfried W, Yoshimura K, Toneyama K, Fukayama M, Stier LE, Paakko PK, Gilardi P, Stratford-Perricaudet LD, Perricaudet M, et al. (1991) Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science 252(5004):431-434
102. Podsakoff G, Wong KK Jr, Chatterjee S (1994) Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J Virol 68(9):5656-5666
103. Samulski RJ (1993) Adeno-associated virus: integration at a specific chromosomal locus. Curr Opin Genet Dev 3(1):74-80
104. Canonico AE, Conary JT, Meyrick BO, Brigham KL (1994) Aerosol and intravenous transfection of human alpha 1-antitrypsin gene to lungs of rabbits. Am J Respir Cell Mol Biol 10(1):24-29
105. Song S, Morgan M, Ellis T, Poirier A, Chesnut K, Wang J, Brantly M, Muzyczka N, Byrne BJ, Atkinson M, Flotte TR (1998) Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc Natl Acad Sci U S A 95(24):14384-14388
106. Flotte TR, Brantly ML, Spencer LT, Byrne BJ, Spencer CT, Baker DJ, Humphries M (2004) Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults. Hum Gene Ther 15(1):93-128
107. No authors listed (1999) Rationale and design of the National Emphysema Treatment Trial (NETT): A prospective randomized trial of lung volume reduction surgery. J Thorac Cardiovasc Surg 118(3):518-528
108. Koebe HG, Kugler C, Dienemann H (2002) Evidence-based medicine: lung volume reduction surgery (LVRS). Thorac Cardiovasc Surg 50(5):315-322
109. Tutic M, Bloch KE, Lardinois D, Brack T, Russi EW, Weder W (2004) Long-term results after lung volume reduction surgery in patients with alpha1-antitrypsin deficiency. J Thorac Cardiovasc Surg 128(3):408-413
110. Mal H, Andreassian B, Pamela F, Duchatelle JP, Rondeau E, Dubois F, Baldeyrou P, Kitzis M, Sleiman C, Pariente R (1989) Unilateral lung transplantation in end-stage pulmonary emphysema. Am Rev Respir Dis 140(3):797-802
111. Low DE, Trulock EP, Kaiser LR, Pasque MK, Dresler C, Ettinger N, Cooper JD (1992) Morbidity, mortality, and early results of single versus bilateral lung transplantation for emphysema. J Thorac Cardiovasc Surg 103(6):1119-1126
112. Cassivi SD, Meyers BF, Barrafarano RJ, Guthrie TJ, Trulock EP, Lynch JP, Cooer JD, Patterson GA (2002) Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg 74(5):1663-1669; discussion 1669-1670
113. King MB, Campbell EJ, Gray BH, Hertz MI (1994) The proteinase- antiproteinase balance in alpha-1-proteinase inhibitor-deficient lung transplant recipients. Am J Respir Crit Care Med 149(4 Pt 1):966-971
114. No authors listed (1998) Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med 158(1):49-59
115. Talamo RC, Langley CE, Reed CE, Makino S (1973) 1-Antitrypsin deficiency: a variant with no detectable 1 -antitrypsin. Science 181(94):70-71
116. Garver RI Jr, Mornex JF, Nukiwa T, Brantly M, Courtney M, LeCocq JP, Crystal RG (1986) Alpha 1-antitrypsin deficiency and emphysema caused by homozygous inheritance of non-expressing alpha 1-antitrypsin genes. N Engl J Med 314(12):762-766
117. Stockley RA, Bayley DL, Unsal I, Dowson LJ (2002) The effect of augmentation therapy on bronchial inflammation in alpha1-antitrypsin deficiency. Am J Respir Crit Care Med 165(11):1494-1498
118. Parfrey H, Dafforn TR, Belorgey D, Lomas DA, Mahadeva R (2004) Inhibiting polymerization: new therapeutic strategies for Z alpha1-antitrypsin-related emphysema. Am J Respir Cell Mol Biol 31(2):133-139
119. Mahadeva R, Dafforn TR, Carrell RW, Lomas DA (2002) 6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin- related cirrhosis. J Biol Chem 277(9):6771-6774